Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Fröhlich-Sorger Elke Verena |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Lohberger, B; Froehlich, EV; Meditz, K; Scheipl, S; Leithner, A; Liegl, B; Rinner, B
Examination of survivin expression in 50 chordoma specimens – a histological and in vitro study.
Abstracts of EMSOS 2016. 2016; -29th Annual Meeting of the European Musculo-Skeletal Oncology Society; MAY 25-27, 2016; La Baule, FRANCE.
[Poster]
Salar-Behzadi, S; Wu, SQ; Meindl, C; Stranzinger, S; Mercuri, A; Mohr, S; Bresciani, M; Khinast, J; Frohlich, E
ADVANCED IN SILICO MODELING OF THE PERFORMANCE OF INHALATION PRODUCTS
J AEROSOL MED PULM D. 2016; 29(3):A19-A19.-DDL26;
[Poster]
Web of Science
Froehlich EV, Hagmüller M
Stimmverstärker - Eine Marktübersicht
Grazer Stimmtage. 2015; -Grazer Stimmtage 2015; NOV 13-14, 2015; Graz, AUSTRIA.
[Oral Communication]
Froehlich EV, Hammer G
Klinische Fallberichte
Grazer Stimmtage. 2015; -Grazer Stimmtage; NOV 13-14, 2015; Graz, VIENNA.
[Oral Communication]
Scheipl, S; Fischer, C; Zopf, A; Deutsch, A; Jorgensen, M; Carvalho, D; Lohberger, B; Froehlich, EV; Leithner, A; Liegl, B; Rinner, B
Mutation analysis of nine chordoma specimens by targeted next generation cancer panel sequencing
VIRCHOWS ARCH. 2014; 465: S326-S326.
[Poster]
Web of Science
Rinner, B; Weinhaeusel, A; Lohberger, B; Froehlich, EV; Pulverer, W; Fischer, C; Meditz, K; Scheipl, S; Trajanoski, S; Guelly, C; Leithner, A; Liegl; B
DNA Methylation markers in chordoma cancer.
Fourth International Chordoma Research Workshop; MAR 21-22, 2013; Boston, MA. 2013.
[Oral Communication]
Scheipl, S; Leithner, A; Rinner, B; Froehlich, EV; Lohberger, B; Liegl, B
Chordoma Research at the Medical University Graz.
LabMeeting UCL Cancer Institute; JAN 23, 2013; London, UNITED KINGDOM. 2013.
[Oral Communication]
Scheipl, S; Lohberger, B; Froehlich, E; Rinner, B; Beham, A; Quehenberger, F; Varga, P; Kaltenegger, H; Haybaeck, J; Leithner, A; Liegl, B
Histone deacetylase inhibitors as potential therapeutic targets for chordomas: An immunohistochemical and functional analysis.
14th EFORT Congress 2013; JUN 5-8, 2013; Istanbul, TURKEY. 2013.
[Oral Communication]
Scheipl, S; Lohberger, B; Froehlich, EV; Rinner, B; Beham, A; Quehenberger, F; Varga, PP; Lazary, A; Haybaeck, J; Leithner, A; Liegl, B;
Histone deacetylase inhibitors as potential therapeutic approaches for chordoma: An immunohistochemical and functional analysis in MUG-chor1.
VIRCHOWS ARCHIV. 2013; 463(2):104-104.-25th European Congress of Pathology; AUG 31 - SEP 4, 2013; Lisbon.
[Oral Communication]
Web of Science
Scheipl, S; Lohberger, B; Froehlich, EV; Rinner, B; Haybaeck, J; Leithner, A; Varga, PP; Quehenberger, F; Liegl, B
Histone deacetylase inhibitors as potential therapeutic targets for
chordomas: an immunohistochemical and functional analysis.
Abstracts of 26th EMSOS; P1:106. 2013; -26th EMSOS; MAY 29-31, 2013; Gothenburg, SWEDEN.
[Poster]
Froehlich, EV; Scheipl, S; Wibmer, C; Varga, PP; Lazary, A; Quehenberger, F; Liegl, B; Leithner, A
Preliminary data of HIF-1á expression in 50 chordoma specimens:
A potential adjuvant therapeutic target?
Abstracts of the 25th Annual Meeting of the European MusculoSkeletal Oncology Society; 056. 2012; 114--25th Annual Meeting of the European MusculoSkeletal Oncology Society; MAY 15-16, 2012; Bologna, ITALY.
[Poster]
Rinner, B; Froehlich, EV; Stuendl, N; Liegl, B; Leithner, A; Lohberger, B
Isolation of ALDH+ cells and investigation of the expression pattern of Wnt pathway genes in the novel sacral chordoma cell line MUG-Chor1.
Abstracts of CYTO 2012, P393;. 2012; 231-232.-CYTO 2012 Annual Meeting; JUN 23-27, 2012; Leipzig, GERMANY.
[Poster]
Scheipl, S; Froehlich, EV; Rinner, B; Lohberger, B; Moinfar, F; Leithner, A; Liegl, B
Tumor-to-tumor Metastasis: Male Breast Carcinoma Metastasis arising in an Extrapleural Solitary Fibrous Tumor a Case Report.
Abstracts of the 25th Annual Meeting of the European MusculoSkeletal Oncology Society; 193. 2012; 240--25th Annual Meeting of the European MusculoSkeletal Oncology Society; MAY 15-16, 2012; Bologna, ITALY.
[Poster]
Wibmer, C; Fröhlich-Sorger, E; Sovinz, P; Maurer-Ertl, W; Leithner, A; Liegl, B
Clear Cell Sarcoma of the gluteal region with a large intraosseous portion in the iliac bone.
Abstracts of the 25th Annual Meeting of the European MusculoSkeletal Oncology Society; 221. 2012; 142--25th Annual Meeting of the European MusculoSkeletal Oncology Society; MAY 15-16, 2012; Bologna, ITALY.
[Poster]
Wibmer, C; Zielonke, N; Sperl, M; Gilg, M; Fröhlich-Sorger, E; Leithner, A
Increasing incidence rates of soft tissue sarcoma? A population-based epidemiologic study and literature review.
Workshop des Forschungsfeldes Krebsforschung; FEB 27, 2012; Graz, AUSTRIA. 2012.
[Oral Communication]
Fröhlich, EV; Scheipl, S; Varga, P; Lazary, A; Schmid, CH; Beham, A; Bodo, K; Schröttner, H; Rinner, B; Quehenberger, F; Windhager, R; Liegl, B; Leithner, A
EZRIN-, MMP-9 AND COX-2 Expression in Chordomas: Microenvironmental Factors and Therapeutic Targets?
Abstracts of the 3rd International Chordoma Research Workshop2011; -Third International Chordoma Research Workshop; MAR 17-19, 2011; Bethesda, Maryland - UNITED STATES.
[Poster]
Fröhlich-Sorger, EV; Scheipl, S; Liegl, B; Windhager, R; Leithner, A
Expression von EZRIN und COX-2 in 44 Chordomfällen: mögliche Targetproteine?
Wissenschaftliche Sitzung der Österreichischen Gesellschaft für Orthopädie und Orthopädische Chirurgie; DEC 3, 2011; Vienna, AUSTRIA. 2011.
[Oral Communication]
Rinner, B; Froehlich, EV; Buerger, K; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Guelly, C; Trajanoski, S; Karoly, S; Liegl, B
Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line: MUG-Chor1.
EuroBoNeT abstracts; Poster presentations RL2.. 2011; -EuroBoNeT Meeting; JAN 11, 2011; Paris, FRANCE.
[Poster]
Rinner, B; Fröhlich, EV; Bürger, K; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Gülly, C; Trajanoski, S; Szuhai, K; Liegl-Atzwanger, B
Establishment and detailed characterisation of a novel sacral chordoma cell line: MUG-Chor1.
Abstracts of the 3rd International Chordoma Research Workshop. 2011; -Third International Chordoma Research Workshop; MAR 17-19, 2011; Bethesda, Maryland - UNITED STATES.
[Oral Communication]
Scheipl, S; Fröhlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, P; Lazary, A; Windhager, R; Liegl, B
Does IGF-1R-Targeting Provide New Treatment Options for Chordomas? A Retrospective Clinical and Immunohistochemical Study on 50 Chordomas Focussing on IGF-receptor 1alpha, IGF-1, and IGF-2.
Abstracts of the 3rd International Chordoma Research Workshop2011; -Third International Chordoma Research Workshop; MAR 17-19, 2011; Bethesda, Maryland - UNITED STATES.
[Poster]
Froehlich, EV; Scheipl, S; Leithner, A; Lazáry, A; Varga, PP; Schmid, CH; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B
MMP9 and COX-2 expression in 52 chordomas preliminary data.
Abstract book of the 8th CEOC meeting 2010;109:A-0034;2010; -8th Central European Orthopaedic Congress; JUNE 16-17, 2010; Pecs, HUNGARY.
[Poster]
Fröhlich, EV; Scheipl, S; Leithner, A; Lazáry, A; Varga, PP; Schmid, CH; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B
Preliminary data of Ezrin-expression in 52 chordomas: microenvironmental factor and therpeutic target?
Abstract book of the 8th CEOC meeting 2010;109:A-0033;2010; -8th Central European Orthopaedic Congress; JUNE 16-17, 2010; Pecs, HUNGARY.
[Poster]
Leithner, A; Froehlich, EV; Scheipl, S; Varga, PP; Lazary, A; Schmid, CH; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B
MMP9 and COX-2 expression in 52 chordomas.
Abstract book of the 23rd EMSOS Meeting 2010;2010; 117-118.-23rd EMSOS Meeting; MAY 5-7, 2010; Birmingham, UNITED KINGDOM.
[Poster]
Leithner, A; Froehlich, EV; Scheipl, S; Varga, PP; Lazary, A; Schmid, CH; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B
Ezrin expression in 52 chordomas: microenvironmental factor and therpeutic target?
Abstract book of the 23rd EMSOS Meeting 2010;2010; 138-139.-23rd EMSOS Meeting; MAY 5-7, 2010; Birmingham, UNITED KINGDOM.
[Poster]
Rinner, B; Froehlich, EV; Scheipl, S; Buerger, K; Szuhai, K; Windhager, R; Beham, A; Leithner, A; Liegl-Atzwanger, B
Establishment of a new chordoma cell line with improved culturing properties.
Abstract-CD, Paper Nr.188.. 2010; -7th Combined Meeting of the Orthopaedic Research Societies; OCT 16-20, 2010; Kyoto, JAPAN.
[Oral Communication]
Rinner, B; Frohlich, E; Scheipl, S; Burger, K; Szuhai, K; Leithner, A; Liegl-Atzwanger, B
ESTABLISHMENT AND CHARACTERIZATION OF A NEW CHORDOMA CELL LINE
CYTOMETRY PART B-CLIN CYTOM. 2010; 78B(6):459-459.-10th Euroconference on Clinical Cell Analysis of the ESCCA and SIC; SEP 11-12, 2010; Valencia, SPAIN.
[Poster]
Web of Science
Scheipl, S; Froehlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, P; Windhager, R; Liegl-Atzwanger, B
Targeted therapies for chordomas: does IGF-1E signaling provide new treatment options?
Abstract book of the 23rd EMSOS Meeting 2010;2010; 119-120.-23rd EMSOS Meeting; MAY 5-7, 2010; Birmingham, UNITED KINGDOM.
[Poster]
Scheipl, S; Fröhlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, PP; Lazáry, A; Windhager, R; Liegl-Atzwanger, B
Does IGF-1R targeting provide new treatment options for chordomas?
Abstract book of the 8th CEOC meeting 2010;107:A-0069;2010; -8th Central European Orthopaedic Congress; JUNE 16-17, 2010; Pecs, HUNGARY.
[Poster]
Scheipl, S; Fröhlich, EV; Leithner, A; Beham, A; Quehenberger, F; Varga, PP; Lazary, A; Stammberger, H; Windhager, R; Liegl-Atzwanger, B
DOES IGF-IR-TARGETING PROVIDE NEW TREATMENT OPTIONS FOR CHORDOMAS?
Abstract-CD, Poster Nr. 266.2010; -7th Combined Meeting of the Orthopaedic Research Societies; OCT 16-20, 2010; Kyoto, JAPAN.
[Poster]
Traunmüller, E; Maurer-Ertl, W; Kürzl, G; Fröhlich, E; Ghaffari-Tabrizi, N; Bodo, K; Liegl, B; Leithner, A
Fibrous dysplasia and pain status in 88 patients.
Abstract book of the 23rd EMSOS Meeting 2010;2010; 79-80.-23rd EMSOS Meeting; MAY 5-7, 2010; Birmingham, UNITED KINGDOM.
[Poster]
Froehlich, EV; Leithner, A; Radl, R; Beham, A; Bodo, K; Schmid, C; Stammberger, H; Barth, A; Schroettner, H; Leithner, K; Quehenberger, F; Liegl, B; Windhager, R
Survivin, DR4 and DR5: Potential targets in future therapy strategies for chordomas?
Abstract book of the 22nd EMSOS, 3.P.45.2009; 134--22nd EMSOS-Meeting; MAY 13-16, 2009; Stuttgart, GERMANY.
[Poster]
Froehlich, EV; Leithner, A; Radl, R; Beham, A; Bodo, K; Schmid, C; Stammberger, H; Barth, A; Schröttner, H; Quehenberger, F; Liegl, B; Windhager, R
Ezrin expression in chordomas: prognostic factor and therapeutic target?
Abstracts and proceedings of the ISOLS/MSTS Meeting 2009;2009; 102--ISOLS/MSTS Combined Meeting; SEP 23-26, 2009; Boston, Massachusetts, UNITED STATES.
[Oral Communication]
Maurer-Ertl, W; Kürzl, G; Fröhlich, E; Leithner, A; Ghaffari-Tabrizi, N; Bodo, K; Liegl, B; Windhager, R
Fibrous dyspalsia and pain: indication for treatment?
Abstract book of the 22nd EMSOS, 3.P.47.2009; 136--22nd EMSOS-Meeting; MAY 13-16, 2009; Stuttgart, GERMANY.
[Poster]
Froehlich, E; Leithner, A; Radl, R; Beham, A; Bodo, K; Stammberger, H; Schmid, C; Barth, A; Schroettner, H; Quehenberger, F; Windhager, R
Examination of prognostic factors in chordomas: a clinical study.
Abstract book of the 7th CEOC2008; 19:5--7th CEOC; JAN 25, 2008; Bratislava, SLOVAKIA.
[Oral Communication]
Fröhlich, E; Leithner, A; Leithner, K; Radl, R; Beham, A; Bodo, K; Stammberger, H; Schmidt, C; Barth, A; Schröttner, H; Quehenberger, F; Windhager, R;
Examination of prognostic factors in chordomas: a clinical and immunohistochemical study.
Monthly conference: National Center For Spinal Disorders; JUNE 4-6, 2008; Budapest, HUNGARY. 2008.
[Oral Communication]
Fröhlich, E; Leithner, A; Radl, R; Beham, A; Bodo, K; Stammberger, H; Schmid, C; Schröttner, H; Quehenberger, F; Windhager, R;
Investigation of prognostic factors in 39 chordoma cases. A clinical study.
Abstracts of Croatian Orthopaedic Congress 2008; 39:302008; -Croatian Orthopaedic Congress; NOV 7-9, 2008; Zagreb, CROATIA.
[Oral Communication]